Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1977 Apr;59(4):585–590. doi: 10.1111/j.1476-5381.1977.tb07725.x

The fate of biogenic monoamines in perfused rabbit lung.

C N Gillis, J A Roth
PMCID: PMC1667755  PMID: 322781

Abstract

1. Inactivation of beta-phenylethylamine and several of its derivatives was studied in a preparation of rabbit lung perfused with Krebs physiological medium at 37 degrees C. Inactivation or removal of these compounds was calculated as the difference between the concentration of each amine in the perfusion medium and the effluent, collected separately from each lung. The extent of amine metabolic degradation was also measured, by column chromatography, in lung effluent. 2. With this technique the magnitude of amine removal as a function of concentration was determined and an apparent Km and Vmax of removal were calculated for each amine. 3. Percentage removal was highest with phenylethylamine (95%), and decreased, apparently in relation to increasing phenyl- and side chain-hydroxylation (and therefore likely increased hydrophilicity), and 5-hydroxytryptamine (64%), tyramine (53%), octopamine (35%), dopamine (32%) and noradrenaline (23%). 4. Inactivation of each amine could be accounted for by metabolic degradation to deaminated products, which appeared in lung effluent within 90 s of beginning amine perfusion. 5. When intrapulmonary metabolism of phenylethylamine was inhibited by simultaneous perfusion with semicarbazide (10 mM) and pargyline (10 micronM), the removal rate was unaltered, establishing that uptake of the amine from the vascular space is not dependent on metabolism at least for 4 min infusions.

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alabaster V. A., Bakhle Y. S. Removal of 5-hydroxytryptamine in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1970 Nov;40(3):468–482. [PMC free article] [PubMed] [Google Scholar]
  2. Alabaster V. A., Bakhle Y. S. The removal of noradrenaline in the pulmonary circulation of rat isolated lungs. Br J Pharmacol. 1973 Feb;47(2):325–331. doi: 10.1111/j.1476-5381.1973.tb08330.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bakhle Y. S., Vane J. R. Pharmacokinetic function of the pulmonary circulation. Physiol Rev. 1974 Oct;54(4):1007–1045. doi: 10.1152/physrev.1974.54.4.1007. [DOI] [PubMed] [Google Scholar]
  4. Bakhle Y. S., Youdim M. B. Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lung. Br J Pharmacol. 1976 Jan;56(1):125–127. doi: 10.1111/j.1476-5381.1976.tb06967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boileau J. C., Crexells C., Biron P. Free pulmonary passage of dopamine. Rev Can Biol. 1972 Mar;31(1):69–72. [PubMed] [Google Scholar]
  6. Gillis C. N., Iwasawa Y. Technique for measurement of norepinephrine and 5-hydroxytryptamine uptake by rabbit lung. J Appl Physiol. 1972 Sep;33(3):404–408. doi: 10.1152/jappl.1972.33.3.404. [DOI] [PubMed] [Google Scholar]
  7. Hughes J., Gillis C. N., Bloom F. E. The uptake and disposition of dl-norepinephrine in perfused rat lung. J Pharmacol Exp Ther. 1969 Oct;169(2):237–248. [PubMed] [Google Scholar]
  8. Junod A. F. Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs. J Pharmacol Exp Ther. 1972 Nov;183(2):341–355. [PubMed] [Google Scholar]
  9. McEwen C. M., Jr, Cullen K. T., Sober A. J. Rabbit serum monoamine oxidase. Purification and characterization. J Biol Chem. 1966 Oct 10;241(19):4544–4556. [PubMed] [Google Scholar]
  10. Neff N. H., Yang H. Y. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sci. 1974 Jun 1;14(11):2061–2074. doi: 10.1016/0024-3205(74)90089-7. [DOI] [PubMed] [Google Scholar]
  11. Nicholas T. E., Strum J. M., Angelo L. S., Junod A. F. Site and mechanism of uptake of 3H--norepinephrine by isolated perfused rat lungs. Circ Res. 1974 Nov;35(5):670–680. doi: 10.1161/01.res.35.5.670. [DOI] [PubMed] [Google Scholar]
  12. Roth J. A., Gillis C. N. Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine. Biochem Pharmacol. 1974 Sep 15;23(18):2537–2545. doi: 10.1016/0006-2952(74)90176-2. [DOI] [PubMed] [Google Scholar]
  13. Roth J. A., Gillis C. N. Multiple forms of amine oxidase in perfused rabbit lung. J Pharmacol Exp Ther. 1975 Sep;194(3):537–544. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES